Discover how Irbesartan reduces inflammatory biomarkers in Type 2 diabetes patients with microalbuminuria, offering new hope for kidney protection.
Explore how plasma pentosidine, an advanced glycation end product, links inflammation and malnutrition in end-stage renal disease patients.
Groundbreaking research reveals how proteinuria and AOPP biomarkers can predict IgA nephropathy progression with remarkable accuracy.